When lipid metabolism was studied in rats with Walker 256 tumors by Seelaender et al. in 1996 [22], the researchers argued that altered lipid metabolism may be associated with decreased LPL activity and hence hypertriglyceridemia. The gene discussed is LPL; the disease is hypertriglyceridemia.